Coeptis Historical Balance Sheet

COEPW Stock  USD 0.02  0  19.50%   
Trend analysis of Coeptis Therapeutics Holdings balance sheet accounts such as Short Long Term Debt Total of 1.6 M, Total Current Liabilities of 2 M or Total Stockholder Equity of 5.8 M provides information on Coeptis Therapeutics' total assets, liabilities, and equity, which is the actual value of Coeptis Therapeutics to its prevalent stockholders. By breaking down trends over time using Coeptis Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Coeptis Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Coeptis Therapeutics is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coeptis Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Coeptis Stock please use our How to Invest in Coeptis Therapeutics guide.

About Coeptis Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Coeptis Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Coeptis Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Coeptis Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Coeptis currently owns. An asset can also be divided into two categories, current and non-current.

Coeptis Therapeutics Balance Sheet Chart

At this time, Coeptis Therapeutics' Net Receivables is fairly stable compared to the past year. Short and Long Term Debt is likely to climb to about 1.4 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 2 M in 2024.

Total Assets

Total assets refers to the total amount of Coeptis Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Coeptis Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Coeptis Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Coeptis Therapeutics Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Coeptis Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Coeptis Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most accounts from Coeptis Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Coeptis Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coeptis Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Coeptis Stock please use our How to Invest in Coeptis Therapeutics guide.At this time, Coeptis Therapeutics' Net Receivables is fairly stable compared to the past year. Short and Long Term Debt is likely to climb to about 1.4 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 2 M in 2024.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total4.1M1.7M2.0M1.6M
Total Assets6.8M7.9M9.1M9.6M

Coeptis Therapeutics balance sheet Correlations

0.720.460.87-0.59-0.96-0.070.990.920.990.420.970.660.990.76-0.71-0.750.880.24-0.98-0.3-0.710.31-0.930.960.18
0.720.790.350.11-0.660.370.640.820.640.270.640.910.640.97-0.29-0.760.86-0.2-0.79-0.71-0.290.75-0.870.84-0.31
0.460.79-0.040.19-0.530.830.450.460.450.130.530.960.450.88-0.26-0.760.83-0.72-0.47-0.3-0.260.31-0.490.48-0.06
0.870.35-0.04-0.8-0.79-0.540.870.770.870.410.80.190.870.35-0.67-0.420.520.67-0.84-0.13-0.670.13-0.760.80.27
-0.590.110.19-0.80.660.44-0.68-0.4-0.68-0.35-0.670.05-0.680.00.590.24-0.29-0.50.5-0.460.590.480.31-0.4-0.66
-0.96-0.66-0.53-0.790.66-0.07-0.98-0.87-0.98-0.43-1.0-0.69-0.98-0.750.650.8-0.89-0.10.940.130.65-0.130.84-0.89-0.29
-0.070.370.83-0.540.44-0.07-0.05-0.08-0.05-0.160.070.66-0.050.480.06-0.460.41-0.970.070.010.06-0.010.07-0.07-0.03
0.990.640.450.87-0.68-0.98-0.050.881.00.420.990.631.00.71-0.75-0.750.870.22-0.95-0.17-0.750.17-0.870.910.29
0.920.820.460.77-0.4-0.87-0.080.880.880.490.850.680.870.82-0.42-0.710.810.26-0.98-0.46-0.420.53-0.960.990.03
0.990.640.450.87-0.68-0.98-0.051.00.880.420.990.631.00.71-0.75-0.750.870.22-0.95-0.17-0.750.17-0.870.910.29
0.420.270.130.41-0.35-0.43-0.160.420.490.420.410.250.420.33-0.140.070.340.13-0.440.06-0.140.03-0.360.420.3
0.970.640.530.8-0.67-1.00.070.990.850.990.410.680.990.74-0.72-0.790.90.1-0.93-0.11-0.720.1-0.830.880.32
0.660.910.960.190.05-0.690.660.630.680.630.250.680.630.97-0.32-0.840.93-0.51-0.68-0.4-0.320.43-0.70.7-0.06
0.990.640.450.87-0.68-0.98-0.051.00.871.00.420.990.630.71-0.76-0.740.870.21-0.95-0.16-0.760.16-0.860.910.3
0.760.970.880.350.0-0.750.480.710.820.710.330.740.970.71-0.35-0.830.94-0.32-0.8-0.53-0.350.57-0.830.83-0.12
-0.71-0.29-0.26-0.670.590.650.06-0.75-0.42-0.75-0.14-0.72-0.32-0.76-0.350.48-0.6-0.160.57-0.071.00.120.51-0.53-0.42
-0.75-0.76-0.76-0.420.240.8-0.46-0.75-0.71-0.750.07-0.79-0.84-0.74-0.830.48-0.880.250.750.290.48-0.290.72-0.74-0.07
0.880.860.830.52-0.29-0.890.410.870.810.870.340.90.930.870.94-0.6-0.88-0.25-0.86-0.32-0.60.33-0.830.850.1
0.24-0.2-0.720.67-0.5-0.1-0.970.220.260.220.130.1-0.510.21-0.32-0.160.25-0.25-0.25-0.11-0.160.11-0.250.250.01
-0.98-0.79-0.47-0.840.50.940.07-0.95-0.98-0.95-0.44-0.93-0.68-0.95-0.80.570.75-0.86-0.250.410.57-0.430.97-0.99-0.07
-0.3-0.71-0.3-0.13-0.460.130.01-0.17-0.46-0.170.06-0.11-0.4-0.16-0.53-0.070.29-0.32-0.110.41-0.07-0.970.61-0.510.83
-0.71-0.29-0.26-0.670.590.650.06-0.75-0.42-0.75-0.14-0.72-0.32-0.76-0.351.00.48-0.6-0.160.57-0.070.120.51-0.53-0.42
0.310.750.310.130.48-0.13-0.010.170.530.170.030.10.430.160.570.12-0.290.330.11-0.43-0.970.12-0.630.54-0.73
-0.93-0.87-0.49-0.760.310.840.07-0.87-0.96-0.87-0.36-0.83-0.7-0.86-0.830.510.72-0.83-0.250.970.610.51-0.63-0.990.14
0.960.840.480.8-0.4-0.89-0.070.910.990.910.420.880.70.910.83-0.53-0.740.850.25-0.99-0.51-0.530.54-0.99-0.01
0.18-0.31-0.060.27-0.66-0.29-0.030.290.030.290.30.32-0.060.3-0.12-0.42-0.070.10.01-0.070.83-0.42-0.730.14-0.01
Click cells to compare fundamentals

Coeptis Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Coeptis Stock Analysis

When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.